市場調査レポート

商品コード

1563367

リアルワールドエビデンスソリューションの市場規模、シェア、収益分析、コンポーネント別、用途別、収益モデル別、展開モード別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Real-World Evidence Solutions Market Size, Share, Growth Analysis, By Component, By Application, By Revenue Model (Pay Per Use, and Subscription), By Deployment Mode, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年09月26日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

リアルワールドエビデンスソリューションの世界市場規模は、2022年に15億4,000万米ドルと評価され、2023年の18億米ドルから2031年には62億6,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは16.9％で成長する見通しです。

リアルワールドエビデンス（RWE）ソリューション市場は、臨床上の意思決定、規制当局の承認、健康アウトカム調査をサポートするために、実世界の環境からのデータを使用することに焦点を当てています。この市場は、エビデンスに基づく医療に対する需要の高まりと、費用対効果の高いヘルスケアソリューションの必要性により、大幅な成長を遂げています。RWEソリューションは、電子カルテ、保険請求、患者登録からの大規模なデータセットを活用し、治療効果、安全性プロファイル、患者の転帰の理解に役立つ洞察を生み出します。慢性疾患の増加と個別化医療の重視の高まりにより、市場は急速に拡大しています。データ分析の技術的進歩や利害関係者間の協力関係の増加も、市場の成長を後押ししています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Merative
Icon Plc
Parexel International Corporation
Oracle Corporation
Trinetx Llc
Trinity
Cognizant Technology Solutions Corporation
Cegedim Health Data
Verantos
Datavant
Tempus
Flatiron Health
Quantzig

Product Code: SQMIG35I2180

Global Real-World Evidence Solutions Market size was valued at USD 1.54 billion in 2022 and is poised to grow from USD 1.80 billion in 2023 to USD 6.26 billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031).

Real-World Evidence (RWE) Solutions Market focuses on the use of data from real-world settings to support clinical decision-making, regulatory approvals, and health outcomes research. This market has experienced substantial growth due to the increasing demand for evidence-based medicine and the need for cost-effective healthcare solutions. RWE solutions leverage large datasets from electronic health records, insurance claims, and patient registries to generate insights that help in understanding treatment effectiveness, safety profiles, and patient outcomes. With the rise in chronic diseases and the growing emphasis on personalized medicine, the market is expanding rapidly. Technological advancements in data analytics and an increasing number of collaborations between stakeholders are also fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Real-World Evidence Solutions Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Real-World Evidence Solutions Market Segmental Analysis

Global Real-World Evidence Solutions Market is segmented on the basis of component, application, revenue model, end user, and region. By component, market is segmented into services, and data sets. By application, market is segmented into drug development & approvals, medical device development & approvals, post-market surveillance, market access & reimbursement/coverage decision-making, and clinical & regulatory decision-making. By revenue model, market is segmented into, pay per use (value-based pricing), and subscription. By deployment mode, market is segmented into on-premise, and cloud-based. By end user, market is segmented into pharmaceutical & medical device companies, healthcare payers, healthcare providers, and other end users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Real-World Evidence Solutions Market

One significant driver of the RWE Solutions Market is the growing demand for personalized medicine. Personalized medicine aims to tailor treatments to individual patient profiles, including genetic, environmental, and lifestyle factors. This approach relies heavily on real-world evidence to validate and optimize personalized treatment strategies. RWE provides insights into how different patient populations respond to treatments in real-world settings, enabling more accurate predictions of efficacy and safety. For instance, pharmaceutical companies utilize RWE to identify patient subgroups that may benefit most from specific therapies, leading to more targeted and effective interventions. As personalized medicine continues to evolve, the need for comprehensive real-world data to support these strategies drives demand for advanced RWE solutions.

Restraints in the Real-World Evidence Solutions Market

A major restraint in the RWE Solutions Market is the growing concern over data privacy and security. Real-world data, including sensitive health information, raises significant privacy issues and regulatory challenges. Stringent data protection regulations, such as the General Data Protection Regulation (GDPR) in Europe and the Health Insurance Portability and Accountability Act (HIPAA) in the US, impose strict requirements on data handling, storage, and sharing. Compliance with these regulations can be complex and costly for organizations seeking to leverage real-world data. Additionally, breaches of data security can lead to severe legal and reputational consequences. Addressing these privacy concerns while ensuring data integrity and security remains a critical challenge for stakeholders in the RWE solutions market.

Market Trends of the Real-World Evidence Solutions Market

A prominent trend in the RWE Solutions Market is the increasing integration of artificial intelligence (AI) and machine learning (ML) technologies. AI and ML enhance the capability to analyze and interpret large volumes of real-world data, uncovering patterns and insights that might not be evident through traditional methods. These technologies facilitate advanced data analytics, enabling more accurate predictions of treatment outcomes, identification of new biomarkers, and optimization of clinical trial designs. For example, AI-driven algorithms can predict patient responses to treatments based on historical data, helping to personalize healthcare strategies and improve patient outcomes. The growing adoption of AI and ML is transforming the RWE landscape, making data analysis more efficient and actionable, and driving innovation across the healthcare industry.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Pricing Analysis
Technology Analysis
Tariff And Regulatory Landscape
Patent Analysis
Customer & Buying Criteria Analysis

Real-World Evidence Solutions Market, By Component

Market Overview
Services
Data Sets
- Disparate Data Sets
- Clinical Settings Data Sets
- Claims Data Sets
- Pharmacy Data Sets
- Patient-Powered Data Sets
- Registry-Based Data Sets
- Integrated Data Sets

Real-World Evidence Solutions Market, By Application

Market Overview
Drug Development & Approvals
- Oncology
- Cardiovascular Disease
- Neurology
- Immunology
- Other Therapeutic Areas
Medical Device Development & Approvals
Post-Market Surveillance
Market Access & Reimbursement/Coverage Decision-Making
Clinical & Regulatory Decision-Making

Real-World Evidence Solutions Market, By Revenue Model

Market Overview
Pay Per Use (Value-Based Pricing)
Subscription

Real-World Evidence Solutions Market, By Deployment Mode

Market Overview
On-Premise
Cloud-Based

Real-World Evidence Solutions Market, By End User

Market Overview
Pharmaceutical & Medical Device Companies
Healthcare Payers
Healthcare Providers
Other End Users

Real-World Evidence Solutions Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Merative
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Icon Plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oracle Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinetx Llc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cognizant Technology Solutions Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cegedim Health Data
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Verantos
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Datavant
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tempus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flatiron Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quantzig
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

リアルワールドエビデンスソリューションの市場規模、シェア、収益分析、コンポーネント別、用途別、収益モデル別、展開モード別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Real-World Evidence Solutions Market Size, Share, Growth Analysis, By Component, By Application, By Revenue Model (Pay Per Use, and Subscription), By Deployment Mode, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

リアルワールドエビデンスソリューション市場：コンポーネント別

リアルワールドエビデンスソリューション市場：用途別

リアルワールドエビデンスソリューション市場：収益モデル別

リアルワールドエビデンスソリューション市場：展開モード別

リアルワールドエビデンスソリューション市場：エンドユーザー別

リアルワールドエビデンスソリューション市場：地域別規模